Raetsch, C <br/><br/>
Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis.  [electronic resource] 

 -  Gut  Feb 2002 
 - 241-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0017-5749 
<br/><br/><label>Standard No.: </label>10.1136/gut.50.2.241  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>Cholestasis--complications<br/>Chronic Disease<br/>Collagen--metabolism<br/>Cytokines--metabolism<br/>DNA Probes--analysis<br/>DNA, Complementary--analysis<br/>Dose-Response Relationship, Drug<br/>Down-Regulation<br/>Enzyme Inhibitors--administration & dosage<br/>Female<br/>Hydroxyproline--analysis<br/>Liver--metabolism<br/>Liver Cirrhosis, Biliary--drug therapy<br/>Liver Cirrhosis, Experimental--metabolism<br/>Pentoxifylline--administration & dosage<br/>Peptide Fragments--metabolism<br/>Procollagen--metabolism<br/>RNA, Messenger--metabolism<br/>Rats<br/>Rats, Wistar<br/>Tissue Inhibitor of Metalloproteinase-1--metabolism